clavulanic acid has been researched along with Tuberculosis, Multidrug-Resistant in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 17 (80.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavanaugh, JS; Cegielski, JP; Dalton, T; Ershova, J; Jou, R; Kurbatova, E; Wu, MH | 1 |
| Alffenaar, JC; Gumbo, T; Srivastava, S; van Rijn, SP; van Soolingen, D; Wessels, MA | 1 |
| Caminero, JA; Mishra, GP | 1 |
| De Wit, S; Payen, MC | 1 |
| Fugemann, F | 1 |
| Bhattacharyya, RP; Hung, DT; Wivagg, CN | 1 |
| Ängeby, K; Bruchfeld, J; Davies Forsman, L; Giske, CG; Juréen, P; Schön, T | 2 |
| Cufré, M; García, A; González Montaner, P; Palmero, D; Poggi, S; Vescovo, M | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
| Caminero, JA; Scardigli, A | 1 |
| Lu, J; Pang, Y; Wang, Y; Zhang, D | 1 |
| Abdo Arbex, M; Akkerman, OW; Alarcon Arrascue, E; Alarcon Guizado, V; Aleska, A; Alffenaar, JW; Avchinko, V; Bonini, EH; Caminero, JA; Centis, R; Chong Marín, FA; Collahuazo López, L; D'Ambrosio, L; De Lorenzo, S; de Vries, G; Dore, S; Gaga, M; Gualano, G; Kunst, H; Matteelli, A; Migliori, GB; Moschos, C; Palmieri, F; Papavasileiou, A; Payen, MC; Roby Arias, AJ; Scardigli, A; Skrahina, A; Solovic, I; Sotgiu, G; Spanevello, A; Sulis, G; Tadolini, M; Tiberi, S; Vargas Vasquez, D; Viggiani, P; White, V; Zumla, A | 1 |
| Abdo Arbex, M; Akkerman, OW; Alarcon Arrascue, E; Alarcon Guizado, V; Aleksa, A; Alffenaar, JW; Artsukevich, J; Auchynka, V; Bonini, EH; Caminero, JA; Centis, R; Chong Marín, FA; Collahuazo López, L; D'Ambrosio, L; De Lorenzo, S; de Vries, G; Dore, S; Gaga, M; Gualano, G; Kunst, H; Matteelli, A; Migliori, GB; Moschos, C; Palmieri, F; Papavasileiou, A; Payen, MC; Piana, A; Roby Arias, AJ; Scardigli, A; Skrahina, A; Solovic, I; Sotgiu, G; Spanevello, A; Sulis, G; Tadolini, M; Tiberi, S; Vargas Vasquez, D; Viggiani, P; White, V; Zumla, A | 1 |
| Bell, DT; Chauhan, V; Kaushik, A; Kumar, P; Lamichhane, G; Stevens, RL; Xia, F | 1 |
| Alffenaar, JW; Bolhuis, MS; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Piana, A; Sotgiu, G; Spanevello, A; Tiberi, S; van Altena, R; Viggiani, P | 1 |
| Drobniewski, F; Gonzalo, X | 1 |
| Dinçer, I; Ergin, A; Kocagöz, T | 1 |
| Abate, G; Miörner, H | 1 |
| Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K | 1 |
| González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME | 1 |
2 review(s) available for clavulanic acid and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
19 other study(ies) available for clavulanic acid and Tuberculosis, Multidrug-Resistant
| Article | Year |
|---|---|
Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clofazimine; Drug Discovery; Drug Resistance, Multiple, Bacterial; Humans; Leprostatic Agents; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.
Topics: Antitubercular Agents; beta-Lactams; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Follow-Up Studies; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2018 |
In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2018 |
[Not Available].
Topics: Antibiotics, Antitubercular; Child; Clavulanic Acid; Drug Therapy, Combination; Humans; Meropenem; Tuberculosis, Multidrug-Resistant | 2016 |
Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Clavulanic Acid; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2015 |
First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina.
Topics: Adult; Antitubercular Agents; Argentina; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Meropenem; Middle Aged; Mycobacterium tuberculosis; Peru; Retrospective Studies; Sputum; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Uruguay; Young Adult | 2015 |
Classification of antituberculosis drugs: a new proposal based on the most recent evidence.
Topics: Antitubercular Agents; Carbapenems; Clavulanic Acid; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Linezolid; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam; Thienamycins; Tuberculosis, Multidrug-Resistant | 2016 |
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Topics: Adult; Antitubercular Agents; Clavulanic Acid; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Meropenem; Retrospective Studies; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2016 |
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Topics: Adult; Antitubercular Agents; Clavulanic Acid; Cohort Studies; Comparative Effectiveness Research; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Sputum; Thienamycins; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2016 |
Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Topics: Administration, Intravenous; Antitubercular Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2015 |
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
Topics: Acetamides; Adult; Antitubercular Agents; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Meropenem; Middle Aged; Oxazolidinones; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2013 |
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
Topics: Amoxicillin; Antitubercular Agents; beta-Lactamases; Clavulanic Acid; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 1998 |
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant | 1999 |
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |